Review Article
Volume 2 Issue 5 - 2020
Recognizing the PPAT of AWS in the AUD-Patient: An Imperative for the Early Screening, Identification, and Treatment of Alcohol Withdrawal Syndrome in Alcohol Use Disorder Patients in Emergency and Intensive Care Settings by Distinguishing AWS Pathophysiology, Progression, Assessment, and Treatment More Directly
Nicholas A Kerna1*, Onyeka Olisemeka2,3, Uzoamaka Nwokorie2,3, Silile Ndhlovu Dube2,3, Emmanuella Solomon2,3, John V Flores4,5 and Mitchell G Jomsky2,3
1SMC–Medical Research, Thailand
2University of Health and Humanities, Tortola, BVI
3University of Science, Arts and Technology, Montserrat, BWI
4Beverly Hills Wellness Surgical Institute, USA
5Orange Partners Surgicenter, USA
*Corresponding Author: Nicholas A Kerna, POB47 Phatphong, Suriwongse Road, Bangkok, Thailand 10500.
Received: April 03, 2020; Published: April 27, 2020


Alcohol use disorder (AUD) is prevalent in 10–20% of hospitalized patients, while trauma patients have a significantly higher prevalence at 31–70%. However, the AUD-patient often goes undetected in an emergency or intensive care setting. Nonetheless, the early identification of AUD-patients can significantly reduce the risks associated with alcohol withdrawal syndrome (AWS). Thus, better understanding the pathophysiology, progression, assessment, and treatment (PPAT) of AWS promotes superior treatment and avoids undue harm to the AUD-patient and staff attending to them. This review article summarizes the PPAT of AWS and provides valuable assessment tools to promptly identify patients with alcohol use disorder (AUD) in the proactive prevention or amelioration of alcohol withdrawal syndrome (AWS).

Keywords: Alcohol Use Disorder; Alcohol Withdraw Syndrome; Emergency Department; Intensive Care


  1. Shea Gregory and Bruce Gresh. “Healthcare in America: Try Thinking This Way - Part 2”. Healthcare Transformation2 (2016): 120.
  2. National Institute of Health. “Alcohol facts and statistics”. National Institute on Alcohol Abuse and Alcoholism (2016).
  3. Rehm J., et al. “Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders”. Lancet 373 (2009): 2223-2233.
  4. Swift RM and Aston ER. “Pharmacotherapy for Alcohol Use Disorder: Current and Emerging Therapies”. Harvard Review of Psychiatry 2 (2015): 122-133.
  5. Soyka M and Lieb M. “Recent Developments in Pharmacotherapy of Alcoholism”. Pharmacopsychiatry4-5 (2015): 123-135.
  6. Franck J and Jayaram-Lindström N. “Pharmacotherapy for alcohol dependence: status of current treatments”. Current Opinion in Neurobiology 4 (2013): 692-699.
  7. Maldonado JR., et al. “Prospective Validation Study of the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) in Medically Ill Inpatients: A New Scale for the Prediction of Complicated Alcohol Withdrawal Syndrome”. Alcohol5 (2015): 509-518.
  8. Sankoff J., et al. “Accomplishing much in a short time: use of a rapid improvement event to redesign the assessment and treatment of patients with alcohol withdrawal”. American Journal of Medical Quality2 (2013): 95-102.
  9. Melkonian A., et al. “Assessment of a Hospital-Wide CIWA-Ar Protocol for Management of Alcohol Withdrawal Syndrome”. Mayo Clinic Proceedings: Innovations, Quality and Outcomes 3 (2019): 344-349.
  10. Saitz R. “Introduction to alcohol withdrawal”. Alcohol Health and Research World 1 (1998): 5-12.
  11. Koob GF and Volkow ND. “Neurocircuitry of addiction”. Neuropsychopharmacology 35 (2010): 217-238.
  12. Lautieri A. “Alcohol Withdrawal Symptoms, Treatment, and Timeline”. American Addiction Centers Last (2020).
  13. Hosking J., et al. “Screening and intervention for alcohol problems among patients admitted following unintentional injury: a missed opportunity?” New Zealand Medical Journal1249 (2007): 22-30.
  14. Wong A., et al. “Multicenter evaluation of pharmacologic management and outcomes associated with severe resistant alcohol withdrawal”. Journal of Critical Care2 (2015): 405-409.
  15. Melson J., et al. “Improving Alcohol Withdrawal Outcomes in Acute Care”. The Permanente Journal 2 (2014): e141-e145.
  16. Salottolo K., et al. “Occurrence, Predictors, and Prognosis of Alcohol Withdrawal Syndrome and Delirium Tremens Following Traumatic Injury”. Critical Care Medicine 5 (2017): 867-874.
  17. Hasin DS., et al. “DSM-5 Criteria for Substance Use Disorders: Recommendations and Rational”. The American Journal of Psychiatry 8 (2013): 834-851.
  18. Romano J. “Early contributions to the study of delirium tremens”. Medical History 3 (1941): 128-139.
  19. Thompson WL. “Management of alcohol withdrawal syndromes”. Archives of Internal Medicine 2 (1978): 278-283.
  20. Franck J and Jayaram-Lindström N. “Pharmacotherapy for alcohol dependence: status of current treatments”. Current Opinion in Neurobiology 4 (2013): 692-699.
  21. , et al. “Using the AUDIT-PC to predict alcohol withdrawal in hospitalized patients”. Journal of General Internal Medicine 29.1 (2014): 34-40.
  22. , et al. “Screening for alcohol abuse using the CAGE questionnaire”. The American Journal of Medicine 82.2 (1987): 231-235.
  23. , et al. “Validation of the MINI (DSM IV) Tool for the Assessment of Alcohol Dependence among Young People in Northern Tanzania Using the Alcohol Biomarker Phosphatidylethanol (PEth)”. International Journal of Environmental Research and Public Health 12.11 (2015): 14021-14033.
  24. Richoux C., et al. “Alcohol use disorders in the emergency ward: choice of the best mode of assessment and identification of at-risk situations”. International Journal of Emergency Medicine 4 (2011): 27.


Citation: Nicholas A Kerna., et al. “Recognizing the PPAT of AWS in the AUD-Patient: An Imperative for the Early Screening, Identification, and Treatment of Alcohol Withdrawal Syndrome in Alcohol Use Disorder Patients in Emergency and Intensive Care Settings by Distinguishing AWS Pathophysiology, Progression, Assessment, and Treatment More Directly”. EC Nursing and Healthcare 2.5 (2020): 03-08.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

May Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the May issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 25, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.